“OF the POOR, by the POOR, OR for the POOR”: COMMUNITY HEALTH CENTERS and the WAR on POVERTY by Kelly Rose O'reilly Disser

Total Page:16

File Type:pdf, Size:1020Kb

“OF the POOR, by the POOR, OR for the POOR”: COMMUNITY HEALTH CENTERS and the WAR on POVERTY by Kelly Rose O'reilly Disser “OF THE POOR, BY THE POOR, OR FOR THE POOR”: COMMUNITY HEALTH CENTERS AND THE WAR ON POVERTY By Kelly Rose O’Reilly Dissertation Submitted to the Faculty of the Graduate School of Vanderbilt University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in History August 31, 2017 Nashville, Tennessee Approved: Sarah Igo, Ph.D. Gary Gerstle, Ph.D. Arleen Tuchman, Ph.D. Theodore Brown, Ph.D. Copyright © 2017 by Kelly Rose O’Reilly All Rights Reserved ACKNOWLEDGEMENTS I consider myself incredibly lucky to have had such a fantastic support system while working on this dissertation. My advisors Sarah Igo and Gary Gerstle have seen this dissertation through its multiple iterations and offered their time and invaluable feedback along the way. Sarah Igo’s thoughtful comments and questions never failed to help me sharpen my research questions and articulate my argument. Gary Gerstle’s thorough feedback on drafts has made me a much better writer. As historians of medicine, Arleen Tuchman and Theodore Brown both contributed their much-needed insight and perspective to my dissertation committee. I greatly appreciate their help and support. Though she was not directly involved in this project, I would also like to thank Alice Kessler-Harris, whose mentorship during my undergraduate years at Columbia helped foster my love of history. This dissertation would not have been possible without financial assistance from Vanderbilt University. Grants from the College of Arts and Sciences have allowed me to travel to complete much of the research that underlies this dissertation. A grant from the Rockefeller Archive Center provided additional help. I also wish to thank the librarians and staff at the Rockefeller Archive Center, the Southern Historical Collection at the University of North Carolina at Chapel Hill, and the National Archives at College Park, Maryland. I benefited greatly from their help and expertise. While most of the research for this dissertation was done in archives, perhaps the most rewarding part of my research occurred outside of these walls. Over the past years, I have had the opportunity to interview several people who were at the core of the community health center program in the 1960s and 1970s. These doctors, nurses, federal employees, and civil rights iii activists graciously agreed to talk with me, and some even welcomed me into their homes. Speaking with them added an invaluable dimension to my dissertation research. I was deeply inspired by their deep, abiding belief that “health care is a human right” and their commitment to putting that principle into practice. Joey Chervenak has been there every step of the way (and become very familiar with the NYC-to-Nashville flight schedules in the process). I cannot imagine the last five years without him. I also extend my gratitude to his parents, Frank and Judy, who have welcomed me into their home and provided so much encouragement. Finally, I am grateful for the love and support of my parents and my sister, Shannon. I could not have done this without them, and I cannot thank them enough. iv TABLE OF CONTENTS Page ACKNOWLEDGEMENTS ............................................................................................ iii INTRODUCTION .......................................................................................................... 1 Chapter 1 Experiments in Community Medicine: Medical Schools in the 1950s .................. 22 An Era of Experimentation ........................................................................... 23 Comprehensive Care .................................................................................... 27 The Navajo-Cornell Field Health Research Project ....................................... 33 The Kentucky Model .................................................................................... 45 2 “An Instrument of Social Change”: Community Health and the Civil Rights Movement ......................................................................................................... 51 Health Activism in the 1960s ........................................................................ 55 Freedom Summer ......................................................................................... 63 Community Organizing for Health ................................................................ 76 A Community Health Center for Mississippi ................................................. 85 3 Community Action Meets Community Health: A New Model for Health Care ..... 88 The War on Poverty and the Lure of Community Action ............................... 90 The OEO: A “Heroic Bureaucracy”? ............................................................. 98 Building a Community Health Center ......................................................... 102 The Community Health Care Model ........................................................... 110 A New Model for Health Care? .................................................................. 122 4 “So Much for Apathy!”: Debating the Meanings of Community Control ............ 125 “Seize the Hospital to Save the People” ...................................................... 128 “Community” Control ................................................................................ 138 Community “Control” ................................................................................ 145 Community Control in Practice .................................................................. 150 “So Much for Apathy!” .............................................................................. 157 5 A Model Under Siege: The Community Health Center Program in the 1970s ..... 159 Giving Control to the Community ............................................................... 163 Changes in Mound Bayou ........................................................................... 166 New Federalism and the Community Health Centers ................................... 171 The Second Nixon and the Battle of Fiscal Austerity .................................. 180 v From Community to Consumers ................................................................. 184 Community Control in Name Only? ............................................................ 189 CONCLUSION: The Radical Promise of Community Health ....................................... 196 The Fate of Community Health ................................................................... 205 A New Consensus: Community Health Centers as Safety Nets .................... 213 BIBLIOGRAPHY ....................................................................................................... 217 LIST OF ACRONYMS ................................................................................................ 228 vi INTRODUCTION In his 1964 State of the Union address, President Lyndon Johnson launched an offensive against poverty in the United States, declaring, “Our aim is not only to relieve the symptom of poverty, but to cure it and, above all, to prevent it.” Invoking the language of disease and sickness, Johnson echoed many of his contemporaries in suggesting that poverty was an illness plaguing an otherwise robust American society—a disease that could be defeated, or “cured,” if only the American people would marshal their resources and rally behind the cause. A heady optimism infused this inauguration of the War on Poverty. Just as American medicine was opening new frontiers in its battles against disease, so too might the government solve long-standing social ills such as poverty. Poverty and disease—once considered regrettable realities—now appeared to be problems that Americans could fight, even conquer. For many Americans, however, this connection between poverty and health may have resonated on a deeper level. By the mid-1960s, the links between poverty and health were clearer than ever before. Physicians and scholars alike had begun to talk about a “health gap,” pointing out that poor Americans were much more likely to suffer from illness than their better- off counterparts were.1 The concept of health itself was also undergoing a transformation. In 1948, the World Health Organization (WHO) had adopted a new definition of health, one unprecedented in its breadth: “Health is a state of complete physical, mental, and social well- being, and not merely the absence of infirmity.”2 By the 1960s, the WHO definition enjoyed 1 Jack Geiger, “Community Health Centers: Health Care as an Instrument of Social Change” in Reforming Medicine: Lessons of the Last Quarter Century, eds. Victor W. Sidel and Ruth Sidel (New York: Pantheon, 1984), 14-15. 2 World Health Organization (WHO), “WHO Definition of Health,” 1948, <http://www.who.int/about/definition/en/print.html> 1 wide acceptance among professionals and experts. Their optimism buoyed by the advances of the civil rights movement, medical reformers believed that a more equitable health care system was within reach.3 With change seemingly on the horizon, reform-minded professionals and experts began to put forward their alternative visions for the future of American health care, testing new ways of extending health care to the poorest citizens. Some of these visions drew on a field that was just recently gaining popularity in medical schools—community medicine. Though the idea of community had a long history in American health policy, community medicine as a separate field only emerged in medical schools in the late 1950s.4 These community medicine depart- ments focused on the entire
Recommended publications
  • The Health Care Experiments at Many Farms: the Navajo, Tuberculosis, and the Limits of Modern Medicine, 1952-1962
    The Health Care Experiments at Many Farms: The Navajo, Tuberculosis, and the Limits of Modern Medicine, 1952-1962 David S. Jones Bulletin of the History of Medicine, Volume 76, Number 4, Winter 2002, pp. 749-790 (Article) Published by The Johns Hopkins University Press DOI: 10.1353/bhm.2002.0186 For additional information about this article http://muse.jhu.edu/journals/bhm/summary/v076/76.4jones.html Access Provided by University of Arizona at 10/04/11 9:13PM GMT The Health Care Experiments at Many Farms: The Navajo, Tuberculosis, and the Limits of Modern Medicine, 1952–1962 DAVID S. JONES summary: In January 1952 a team of medical researchers from Cornell Medical College learned that tuberculosis raged untreated on the Navajo Reservation in Arizona. These researchers, led by Walsh McDermott, recognized a valuable opportunity for medical research, and they began a ten-year project to evaluate the efficacy of new antibiotics and test the power of modern medicine to improve the health conditions of an impoverished rural society. The history of this endeavor exposes a series of tensions at the heart of medical research and practice. Researchers exploited the opportunities made possible by the ill-health of a marginalized population, but did so with the cooperation and gratitude of the Navajo. They introduced new antibiotics that liberated patients from hospitals, but erected an intrusive system of outpatient surveillance. They provided innovative health-care services, but failed to reduce the dominant causes of morbidity and mortality. As every act of treatment became an experiment, they risked undermining the trust on which research and clinical care depended.
    [Show full text]
  • Antimicrobial Therapy of Pulmonary Tuberculosis *
    Bull. Org. mond. Sante 1960, 23 427-461 Bull. Wld Hlth Org. Antimicrobial Therapy of Pulmonary Tuberculosis * WALSH McDERMOTT, M.D.' The discovery, some nine years ago, ofthe highly specific antituberculous drug, isoniazid, marked an important advance in the antimicrobial therapy of tuberculosis, first practised successfully with streptomycin and p-aminosalicylic acid (PAS) in the late 'forties. Isoniazid is relatively non-toxic and, unlike streptomycin, can be administered orally, so that it is eminently suitable for use, either alone or in combination with PAS, in the domi- ciliary treatment of tuberculous patients. The wisdom of employing it on a large scale in home-treatment programmes, however, has been questioned on the ground that such wide- spread use might result in a spread of tubercle bacilli resistant to the drug. This contro- versial subject is discussed in some detail in this general review of the chemotherapy of tuberculosis. The author is convinced that, so far, the benefits of isoniazid therapy have outweighed the disadvantages and, though well aware of the possible consequences in terms of isoniazid-resistance, sees no reason at the present time for not making full use of this valuable weapon in the antituberculosis armamentarium. INTRODUCTION It is now approximately fifteen years since the first mena that had already been quite well established successful demonstration of the antimicrobial from the chemotherapy of other infections. One therapy of tuberculosis and it is highly appropriate can always find fault with what is going on around that we take stock of the situation at this time. The one, however, and despite these annoyances things fifteen-year period has been one of great achieve- have, on the whole, certainly progressed very well.
    [Show full text]
  • WALSH Mcdermott October 24, 1909-October 11,1981
    NATIONAL ACADEMY OF SCIENCES W A L S H M C D ERMOTT 1909—1981 A Biographical Memoir by P A U L B . B EESON Any opinions expressed in this memoir are those of the author(s) and do not necessarily reflect the views of the National Academy of Sciences. Biographical Memoir COPYRIGHT 1990 NATIONAL ACADEMY OF SCIENCES WASHINGTON D.C. WALSH McDERMOTT October 24, 1909-October 11,1981 BY PAUL B. BEESON ALSH MCDERMOTT'S professional life divides into two Wphases. Until his mid-forties he followed a highly pro- ductive career in academic clinical medicine and laboratory investigation. He then decided to shift emphasis and work in the field of public health at the local, national, and interna- tional levels. From this vantage point he played an influential role in the development of national health policy and the reorganization of U.S. medical research, earning recognition as a leading statesman in American medicine. EDUCATION AND EARLY LIFE McDermott was born on October 24, 1909, in New Haven, Connecticut, where his father was a family doctor. His mother, the former Rosella Walsh, came from Massachusetts. After attending New Haven public schools and Andover, he went to Princeton for premedical studies, receiving the B.A. degree in 1930. He then entered Columbia University's Col- lege of Physicians and Surgeons, earning the M.D. degree in 1934. In college and medical school he had little financial support and had to obtain scholarships as well as part-time jobs. For residency he moved across Manhattan Island to the New York Hospital.
    [Show full text]
  • Antibiotic Treatment of Syphilis
    Memling, 15th Century Florence Nightingale in Scutari IGNAZ PHILIPP SEMMELWEIS EFFECTEFFECT OFOF HANDHAND WASHING*WASHING* ONON DEATHSDEATHS DUEDUE TOTO PUERPERALPUERPERAL SEPSISSEPSIS ININ VIENNAVIENNA Date Mortality (%) May 12.2% June 2.38 July 1.30 August 1.89 Average 1.27 (after hand washing) 1.33 (in Second Clinic) *Introduced in May, 1847 by I.P. Semmelweis THETHE FIRSTFIRST ANTIMICROBIALANTIMICROBIAL DRUGS:DRUGS: SULFONAMIDESSULFONAMIDES –– MODIFIEDMODIFIED RAPTURERAPTURE •• 1935,1935, DomagkDomagk reportsreports ProntosilProntosil curescures micemice givengiven lethallethal dosesdoses ofof hemolytichemolytic streptococci.streptococci. •• EncouragingEncouraging resultsresults inin patientspatients withwith pneumococcalpneumococcal pneumoniapneumonia ((equalequal toto serumserum therapy),therapy), meningococcalmeningococcal meningitis,meningitis, erysipelas,erysipelas, mastoiditismastoiditis,, puerperalpuerperal sepsis.sepsis. •• DisappointingDisappointing resultsresults inin streptococcalstreptococcal pharyngitispharyngitis (persistent(persistent colonization,colonization, recurrences,recurrences, diddid notnot preventprevent rheumaticrheumatic fever),fever), andand gramgram--negativenegative infections.infections. •• RapidRapid developmentdevelopment ofof resistanceresistance andand frequentfrequent sideside effects.effects. INITIALINITIAL TREATMENTSTREATMENTS WITHWITH PENICILLINPENICILLIN • 1941 – In February, enough penicillin produced in modified bed pans to treat an Oxford policeman, Albert Alexander, who suffered from widespread
    [Show full text]
  • Studies of Microbial Populations Artificially Localized in Vivo
    STUDIES OF MICROBIAL POPULATIONS ARTIFICIALLY LOCALIZED IN VIVO. II. DIFFERENCE IN ANTITYPHOIDAL ACTIVITIES OF CHLORAMPHENICOL AND CHLORTETRACYCLINE Charles A. Werner, … , Carol Adams, Rebeckah DuBois J Clin Invest. 1954;33(5):753-758. https://doi.org/10.1172/JCI102944. Research Article Find the latest version: https://jci.me/102944/pdf STUDIES OF MICROBIAL POPULATIONS ARTIFICIALLY LOCAL- IZED IN VIVO. II. DIFFERENCE IN ANTITYPHOIDAL ACTIVITIES OF CHLORAMPHENICOL AND CHLORTETRACYCLINE 1 By CHARLES A. WERNER2 AND WALSH McDERMOTT WITH THE TECHNICAL AS- SISTANCE or CAROL ADAMS AND REBECKAH DuBOIS (From the Department of Medicine, New York Hospital-Cornell University Medical Center, New York, N. Y.) (Submitted for publication August 5, 1953; accepted January 13, 1954) It has long been recognized that only a few treatment of typhoid fever in humans. Both compounds which exhibit antimicrobial activity chlortetracycline and chloramphenicol have been in vitro are capable of manifesting comparable ac- demonstrated to be highly active in relatively low tivity when introduced into mammalian hosts. concentration against a wide spectrum of patho- The different pharmacologic and microbiologic genic microorganisms including S. typhosa (5, 6), factors which may be responsible for chemothera- and both drugs have been found to be effective in peutic failure -have been reviewed elsewhere ( 1, 2). the treatment of a large number of infections in- In general, however, if a particular drug is capable cluding intracellular infections other than typhoid, of exerting powerful antimicrobial action in sivo such as scrub and murine typhus and acute brucel- against certain pathogens, that drug will be simi- losis (7-9). VVWhile chloramphenicol has been larly effective against all pathogenic bacteria which highly successful in the treatment of typhoid, are inhibited by low concentrations of the drug in chlortetracycline has been only negligibly effective vitro.
    [Show full text]
  • RES2 33.Pdf (2.613Mb)
    -, * PAN AMERICAN HEALTH SECOND MEETING ORGANIZATION 17-21 June 1963 Washington, D.C. ADVISORY COMMITTEE ON MEDICAL RESEARCH a 4 REPORT TO THE DIRECTOR siue Copy Pan Amner;ian Sa-'itary Bieau 0 Library *? '" !S63 Ref: RES 2/33 21 June 1963 PAN AMERICAN HEALTH ORGANIZATION Pan American Sanitary Bureau, Regional Office of the WORLD HEALTH ORGANIZATION WASHINGTON, D.C. RES 2/33 PAHO ADVISORY COMMITTEE ON MEDICAL RESEARCH Dr. Hernán Alessandri Dr. Horace W. Magoun Decano, Facultad de Medicina Dean, Graduate Division Universidad de Chile University of California Santiago, Chile Los Angeles, California Dr. Gaylord W. Anderson Dr. Walsh McDermott (Chairman) Director, School of Public Health Chairman, Department of Public Health University of Minnesota Cornell University Medical College Minneapolis, Minnesota New York, New York 4 Dr. Carlos Chagas (Vice-Chairman) Dr. Karl F. Meyer * Director, Instituto de Biofisica Director Emeritus, George Williams Universidade do Brasil Hooper Foundation for Medical Rio de Janeiro, Brasil Research University of California Medical Center Dr. Ignacio Chávez San Francisco, California Rector, Universidad Nacional Aut6noma de México Dr. Anthony M.-M. Payne (Rapporteur) México, D. F., México Chairman, Department of Epidemiology and Public Health Dr. René Dubos Yale University School of Medicine Professor and Member New Haven, Connecticut The Rockefeller Institute New York, New York Dr. Marcel Roche (Rapporteur) Director, Instituto Venezolano de Dr. Bernardo A. Houssay Investigaciones Cientificas Director, Instituto de Biologia Caracas, Venezuela y Medicina Experimental Buenos Aires, Argentina Dr. James A. Shannon Director, National Institutes Dr. Niels K. Jerne of Health Chairman, Department of Microbiology Bethesda, Maryland School of Medicine University of Pittsburgh Prof.
    [Show full text]